Effect of SstI polymorphism of the apolipoprotein CIII gene and environmental factors on risks of hypertriglyceridemia in Taiwan aborigines

Circulation Journal

Volumn 70, Issue 8, 2006, Pages 1030-1036

  Huang, Meng Chuan ^a,b   Wang, Tsu Nai ^c   Liu, Yi Ling ^a   Pa, Te Hsiung ^d   Tu, Hung Ping ^a   Huang, Yi Chia ^e   Chang, Wen Tsan ^b   Ko, Ying Chin ^a,f  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d Taimali Township Public Health Center   (Taiwan)

^e CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^f NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

Author keywords

Apolipoprotein CIII SstI; HindIII; Hypertriglyceridemia; Lipoprotein lipase polymorphism; Taiwan aborigines

Indexed keywords

APOLIPOPROTEIN C3; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN LIPASE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; URIC ACID;

ABORIGINE; ADULT; AGED; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; EDUCATION; ENVIRONMENTAL FACTOR; ETHNIC DIFFERENCE; FEMALE; FOOD INTAKE; GENE DOSAGE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; HUMAN; HUMAN TISSUE; HYPERTRIGLYCERIDEMIA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PREVALENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL;

AGED; APOLIPOPROTEIN C-III; APOLIPOPROTEINS C; ARECA; BODY MASS INDEX; CROSS-SECTIONAL STUDIES; DIETARY CARBOHYDRATES; EDUCATION; FEMALE; GENE FREQUENCY; HUMANS; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN LIPASE; MALE; MIDDLE AGED; OCEANIC ANCESTRY GROUP; POLYMORPHISM, GENETIC; PREVALENCE; REGRESSION ANALYSIS; RISK FACTORS; SMOKING; SOCIAL ENVIRONMENT; TAIWAN; TRIGLYCERIDES;

EID: 33746729504     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.1030     Document Type: Article

References (58)

1. Assmann G, Cullen P, Schulte H. The Munster Heart Study (PROCAM): Results of follow-up at 8 years. Eur Heart J 1998; 19: A2-A11.
2. Austin MA, Hokanson JE, Edwards KL. Hypertriglyceridemia as a cardiovascular risk factor. Am J Cardiol 1998; 81(4A): 7B-12B
3. National Cholesterol Education Program Expert Panel. National Institutes of Health: Third Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Tretament of High Blood Cholesterol in Adults (Adult Treatment Panel III). Bethesda, MD: NIH; 2002. NIH Publication 100 01-3670.
4. Breslow JL. Mouse models of atherosclerosis. Science 1996; 27: 685-688.
5. Department of Health, Executive Yuan, ROC. Nutrition and health Survey in Taiwan, NAHSIT, 1993-1996. Taipei, Republic of China, 1998.
6. Department of Health, Executive Yuan, ROC. Date of creation: December, 2002; Date of viewing: June, 2006.
7. Ko Y-C, Liu B-H, Hsieh S-F. Issues on aboriginal health in Taiwan. Kaohsiung J Med Sci 1994; 10: 337-351.
8. Department of Health, Executive Yuan, ROC. Health and Vital statistics Vol 2: Vital statistics. Taipei, Republic of China, 2004.
9. Bruns GA, Karathanasis SK, Breslow JL. Human apolipoprotein A-I- C-III gene complex is located on chromosome 11. Arteriosclerosis 1984; 4: 97-102.
10. Wang CS, McConathy WJ, Kloer HU, Alaupovic P. Modulation of lipoprotein lipase activity by apolipoproteins: Effect of apolipoprotein C-III. J Clin Invest 1985; 75: 384-390.
11. Schonfeld G, George PK, Miller J, Reilly P, Witztum J. Apolipoprotein C-II and C-III levels in hyperlipoproteinemia. Metabolism 1979; 28: 1001-1010.
12. Bai H, Saku K, Liu R, Imamura M, Arakawa K. Association between coronary heart disease and the apolipoprotein A-I/C-III/A-IV complex in a Japanese population. Hum Genet 1995; 95: 102-104.
13. Chhabra S, Narang R, Krishnan LR, Vasisht S, Agarwal DP, Srivastava LM, et al. Apolipoprotein CIII SstI polymorphism and triglyceride levels in Asian Indians. BMC Genet 2002; 3: 9.
14. Dammerman M, Sandkuijl LA, Halaas JL, Chung W, Breslow JL. An apolipoprotein CIII haplotype protective against hypertriglyceridemia is specified by promoter and 3′ untranslated region polymorphisms. Proc Natl Acad Sci USA 1993; 90: 4562-4566.
15. Tybjaerg-Hansen A, Nordestgaard BG, Gerdes LU, Faergeman O, Humphries SE. Genetic markers in the apo AI-CIII-AIV gene cluster for combined hyperlipidemia, hypertriglyceridemia, and predisposition to atherosclerosis. Atherosclerosis 1993; 100: 157-169.
16. Ko YL, Ko YS, Wu SM, Teng MS, Chen FR, Hsu TS, et al. Interaction between obesity and genetic polymorphisms in the apolipoprotein CIII gene and lipoprotein lipase gene on the risk of hypertriglyceridemia in Chinese. Hum Genet 1997; 100: 327-333.
17. Johansen K, Dunn B, Tan JC, Kwaasi AA, Skotnicki A, Skotnicki M. Coronary artery disease and apolipoprotein A-I/C-III gene polymorphism: A study of Saudi Arabians. Clin Genet 1991; 39: 1-5.
18. Wu JH, Kao JT, Wen MS, Lo SK. DNA polymorphisms at the apolipoprotein A1-CIII loci in Taiwanese: Correlation of plasma APOCIII with triglyceride level and body mass index. J Formos Med Assoc 2000; 99: 367-374.
19. Sparkes RS, Zollman S, Klisak I, Kirchgessner TG, Komaromy MC, Mohandas T, et al. Human genes involved in lipolysis of plasma lipoproteins: Mapping of loci for lipoprotein lipase to 8p22 and hepatic lipase to 15q21. Genomics 1987; 1: 138-144.
20. Razzaghi H, Aston CE, Hamman RF, Kamboh MI. Genetic screening of the lipoprotein lipase gene for mutations associated with high triglyceride/low HDL-cholesterol levels. Hum Genet 2000; 107: 257-267.
21. Peacock RE, Hamsten A, Nilsson-Ehle P, Humphries SE. Associations between lipoprotein lipase gene polymorphisms and plasma correlations of lipids, lipoproteins and lipase activities in young myocardial infarction survivors and age-matched healthy individuals from Sweden. Atherosclerosis 1992; 97: 171-185.
22. Anderson JL, King GJ, Bair TL, Elmer SP, Muhlestein JB, Habashi J, et al. Association of lipoprotein lipase gene polymorphisms with coronary artery disease. J Am Coll Cardiol 1999; 33: 1013-1020.
23. Department of Population. Consensus 1990: Census report of the Republic of China in Taiwan. Taipei, ROC, 1992.
24. Bellwood P. The Austronesian dispersal and the origin of languages. Sci Am 1991; 265: 70-75.
25. Blust R. The Austronesian homeland: A linguistic perspective. Asian Perspect 1988; 26: 45-67.
26. Melton T, Peterson R, Redd AJ, Saha N, Sofro AS, Martinson J, et al. Polynesian genetic affinities with Southeast Asian populations as identified by mtDNA analysis. Am J Hum Genet 1995; 57: 403-414.
27. Zeng Q, Dammerman M, Takada Y, Matsunaga A, Breslow JL, Sasaki J. An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population. Hum Genet 1995; 95: 371-375.
28. Russo GT, Meigs JB, Cupples LA, Demissie S, Otvos JD, Wilson PW, et al. Association of the Sst-I polymorphism at the APOCIII gene locus with variations in lipid levels, lipoprotein subclass profiles and coronary heart disease risk: The Framingham offspring study. Atherosclerosis 2001; 158: 173-181.
29. Rees A, Shoulders CC, Stocks J, Galton DJ, Baralle FE. DNA polymorphism adjacent to human apoprotein A-1 gene: Relation to hypertriglyceridaemia. Lancet 1983; 1: 444-446.
30. Ferns GA, Stocks J, Ritchie C, Galton DJ. Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction. Lancet 1985; 2: 300-303.
31. O'Connor G, Stocks J, Lumley J, Galton DJ. A DNA polymorphism of the apolipoprotein C-III gene in extracoronary atherosclerosis. Clin Sci (Lond) 1988; 74: 289-292.
32. Price WH, Morris SW, Kitchin AH, Wenham PR, Burgon PR, Donald PM. DNA restriction fragment length polymorphisms as markers of familial coronary heart disease. Lancet 1989; 1: 1407-1411.
33. Rees A, Stocks J, Williams LG, Caplin JL, Jowett NI, Camm AJ, et al. DNA polymorphisms in the apolipoprotein C-III and insulin genes and atherosclerosis. Atherosclerosis 1985; 58: 269-275.
34. Dallinga-Thie GM, Bu XD, van Linde-Sibenius Trip M, Rotter JI, Lusis AJ, de Bruin TW. Apolipoprotein A-I/C-III/A-IV gene cluster in familial combined hyperlipidemia: Effects on LDL-cholesterol and apolipoproteins B and C-III. J Lipid Res 1996; 37: 136-147.
35. Dallinga-Thie GM, van Linde-Sibenius Trip M, Rotter JI, Cantor RM, Bu X, Lusis AJ, et al. Complex genetic contribution of the Apo AI-CIII-AIV gene cluster to familial combined hyperlipidemia: Identification of different susceptibility haplotypes. J Clin Invest 1997; 99: 953-961.
36. Shoulders CC, Harry PJ, Lagrost L, White SE, Shah NF, North JD, et al. Variation at the apo AI/CIII/AIV gene complex is associated with elevated plasma levels of apo CIII. Atherosclerosis 1991; 87: 239-247.
37. Shoulders CC, Grantham TT, North JD, Gaspardone A, Tomai F, de Fazio A, et al. Hypertriglyceridemia and the apolipoprotein CIII gene locus: Lack of association with the variant insulin response element in Italian school children. Hum Genet 1996; 98: 557-566.
38. Karathanasis SK. Apolipoprotein multigene family: Tandem organization of human apolipoprotein AI, CIII, and AIV genes. Proc Natl Acad Sci USA 1985; 82: 6374-6378.
39. Hong SH, Park WH, Lee CC, Song JH, Kim JQ. Association between genetic variations of apo AI-CIII-AIV cluster gene and hypertriglyceridemic subjects. Clin Chem 1997; 43: 13-17.
40. Sidoli A, Giudici G, Soria M, Vergani C. Restriction-fragment-length polymorphisms in the A-I-C-III gene complex occurring in a family with hypoalphalipoproteinemia. Atherosclerosis 1986; 62: 81-87.
41. Marcil M, Boucher B, Gagne E, Davignon J, Hayden M, Genest J Jr. Lack of association of the apolipoprotein A-I-C-III-A-IV gene XmnI and SstI polymorphisms and of the lipoprotein lipase gene mutations in familial combined hyperlipoproteinemia in French Canadian subjects. J Lipid Res 1996; 37: 309-319.
42. Rees A, Stocks J, Paul H, Ohuchi Y, Galton D. Haplotypes identified by DNA polymorphisms at the apolipoprotein A-1 and C-III loci and hypertriglyceridaemia: A study in a Japanese population. Hum Genet 1986; 72: 168-171.
43. Ordovas JM, Schaefer EJ. Genes, variation of cholesterol and fat intake and serum lipids. Curr Opin Lipidol 1999; 10: 15-22.
44. Salas J, Jansen S, Lopez-Miranda J, Ordovas JM, Castro P, Marin C, et al. The SstI polymorphism of the apolipoprotein C-III gene determines the insulin response to an oral-glucose-tolerance test after consumption of a diet rich in saturated fats. Am J Clin Nutr 1998; 68: 396-401.
45. Li WW, Dammerman MM, Smith JD, Metzger S, Breslow JL, Leff T. Common genetic variation in the promoter of the human apo CIII gene abolishes regulation by insulin and may contribute to hypertriglyceridemia. J Clin Inves 1995; 96: 2601-2605.
46. Waterworth DM, Ribalta J, Nicaud V, Dallongeville J, Humphries SE, Talmud P. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation 1999; 99: 1872-1877.
47. Espino-Montoro A, Barrios-Artillo M, Lopez-Chozas JM, Cayuela A, Stiefel P, Villar J. Influence of polymorphism (RFLP-sstI) at the apolipoprotein C-III gene locus on the lipoprotein metabolism and insulin resistance in essential hypertensive patients-Interaction between gender and genetic polymorphism. Nutr Metab Cardiovasc Dis 2003; 13: 194-201.
48. Dallongeville J, Meirhaeghe A, Cottel D, Fruchart JC, Amouyel P, Helbecque N. Gender related association between genetic variations of APOC-III gene and lipid and lipoprotein variables in northern France. Atherosclerosis 2000; 150: 149-157.
49. Dennis BH, Zhukovsky GS, Shestov DB, Davis CE, Deev AD, Kim H, et al. The association of education with coronary heart disease mortality in the USSR Lipid Research Clinics Study. Int J Epidemiol 1993; 22: 420-427.
50. Thomas GN, Ho SY, Lam KS, Janus ED, HedLey AJ, Lam TH, Hong Kong Cardiovascular Risk Factor Prevalence Study Steering Committee. Impact of obesity and body fat distribution on cardiovascular risk factors in Hong Kong Chinese. Obes Res 2004; 12: 1805-1813.
51. Zhang H, Tamakoshi K, Yatsuya H, Murata C, Wada K, Otsuka R, et al. Long-term body weight fluctuation is associated with metabolic syndrome independent of current body mass index among Japanese men. Circ J 2005; 69: 13-18.
52. Ryo M, Nakamura T, Kihara S, Kumada M, Shibazaki S, Takahashi M, et al. Adiponectin as a biomarker of the metabolic syndrome. Circ J 2004; 68: 975-981.
53. Fried SK, Rao SP. Sugars, hypertriglyceridemia, and cardiovascular disease. Am J Clin Nutr 2003; 78: 873S-880S.
54. Kamel BS, Martenez OB. Food habits and nutrient intake in Kuwaiti in males and females. Ecol Food Nutr 1985; 15: 261-272.
55. Miwa K, Okinaga S, Fujita M. Low serum alpha-tocopherol concentrations in subjects with various coronary risk factors. Circ J 2004; 68: 542-546.
56. Humphries SE, Nicaud V, Margalef J, Tiret L, Talmud PJ. Lipoprotein lipase gene variation is associated with a paternal history of premature coronary artery disease and fasting and postprandial plasma triglycerides: The European Atherosclerosis Research Study (EARS). Arterioscler Thromb Vasc Biol 1998; 18: 526-534.
57. Chamberlain JC, Thorn JA, Oka K, Galton DJ, Stocks J. DNA polymorphisms at the lipoprotein lipase gene: Associations in normal and hypertriglyceridaemic subjects. Atherosclerosis 1989; 79: 85-91.
58. Corella D, Guillen M, Saiz C, Portoles O, Sabater A, Folch J, et al. Associations of LPL and APOCIII gene polymorphisms on plasma lipids in a Mediterranean population: Interaction with tobacco smoking and the APOE locus. J Lipid Res 2002; 43: 416-427.